Book by the South Centre, 2002
Protection of Data Submitted for the Registration of Pharmaceuticals: Implementing the Standards of the TRIPS Agreement
This study focuses in depth on the specific issue of marketing approval protection under the TRIPS Agreement and its interpretation, an issue of major practical importance for the developing countries. This book is co-published by the World Health Organization and was produced with the support of the Rockefeller Foundation.
This article was tagged: Access to Medicines, Data Exclusivity, Generic Medicines, Health, Intellectual Property, Patent, Public Health, TRIPS
